The KNL1 gene helps cells keep chromosomes lined up and evenly shared when a cell divides. The protein made by this gene helps your cells build the attachment point that guides this process. If the gene does not work well, cells can divide in a less controlled way, which may affect growth before birth and brain development. People with two nonworking copies can have a condition linked to a smaller head size at birth, developmental delay, and short stature.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which carry out much of the cell’s work. Other genes mainly control when certain processes occur, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic further, you can read more in the LearnHub.
Overview
KNL1Gene function
What if the gene works
The KNL1 gene helps cells divide by organizing the machinery that lines up and separates chromosomes. It also supports the checkpoint that pauses division until chromosomes are attached correctly.
Risk
What if the gene does not work
More disruptive variants in the KNL1 gene can cause very small head size from birth, developmental delay or intellectual disability, and sometimes short stature or growth restriction. Milder variants may lead to later, less marked, or fewer features.
Treatment
What does that mean for your treatment
For pathogenic variants in the KNL1 gene, no KNL1-specific treatment or medication approach is currently established. The KNL1 gene is being studied in cancer research as a marker of cell division and a possible drug target.
Conditions associated with KNL1
Gene function
What if the gene works
When cells divide, timing and organization matter. The KNL1 gene helps coordinate this process by supporting the structure that links chromosomes to the cell’s pulling system. This keeps cell division orderly and helps each new cell receive the right set of chromosomes.
The KNL1 gene helps organize the kinetochore (the anchor point on each chromosome) during cell division. This gives spindle fibers, the tiny threads that pull chromosomes apart, a stable place to attach.
KNL1 helps bring in checkpoint proteins, which act as a built in safety check before chromosomes separate. This is a central part of how the KNL1 gene supports cell division with careful timing.
By supporting firm chromosome attachments, the KNL1 gene helps chromosomes line up across the middle of the cell before they separate. This orderly setup prepares the cell for the next step of division.
Signals organized around KNL1 help the cell move one copy of each chromosome to each new cell. This supports accurate sharing of genetic material during routine growth and tissue renewal.
What is a variant?
Genetic variants are small changes in the DNA sequence within a gene. They are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some instances, though, a variant can more strongly change how a gene functions and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
To understand how variants influence the KNL1 gene's function, it helps to know that some changes shorten the protein or make it less stable. This can weaken the kinetochore, the chromosome-handling structure that helps cells divide in an orderly way, and may disrupt the checkpoint signals that pause division when something is wrong. Milder variants may leave some activity in place, while more severe variants can cause a much larger loss of function and are often linked to earlier or more pronounced effects.
How variants are linked to conditions
Variants in both copies of the KNL1 gene cause a rare inherited condition marked by primary microcephaly, meaning a baby’s head and brain are much smaller than expected from birth. Many children with this condition also have short stature, developmental delay, and learning difficulties. In summaries of how KNL1 variants are linked to conditions, this pattern of growth and brain differences is the main well established association.
A variant is not necessarily a diagnosis
Variants are a usual part of human biology and are found commonly throughout the general population. Most have no direct impact on health and instead reflect natural human diversity. For many genes, carrying a variant tied to a condition suggests a possible association, not a definite diagnosis, especially when more than one gene and environmental factors are involved. In other cases, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KNL1, there is no broadly confirmed evidence that lifestyle or everyday exposures meaningfully change risk. When KNL1-related conditions occur, risk is mainly shaped by inheritance, especially if both biological parents carry a disease-causing change in the KNL1 gene. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of KNL1 variants
KNL1-related conditions are inherited in an autosomal recessive pattern. When looking at how variants of the KNL1 gene are inherited, this means a child usually needs to receive one altered copy from each parent to be affected. Parents who each carry one KNL1 variant are typically unaffected themselves, and with each pregnancy there is a 25% chance their child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy.
What does my KNL1 result mean for my family?
For families with a disease-causing change in the KNL1 gene, the condition is usually passed down in a recessive pattern. This often means parents are healthy carriers, and brothers or sisters may also be carriers or, less often, may also have the condition. Other relatives on both sides of the family could be carriers too, especially close blood relatives.
Genetic information
Genetic testing
How you find out about variants
Variants in the KNL1 gene are found with genetic testing, often called KNL1 genetic testing, using a blood, saliva, or cheek swab sample. The lab reads the DNA code to look for spelling changes and may also check for missing or extra pieces of DNA.
When should I consider getting a genetic test?
Genetic testing for the KNL1 gene may be worth considering when a baby or child has a much smaller head size than expected, slow growth, or developmental delays, especially if similar findings run in the family. It can also help when a pregnancy scan shows these changes or when a relative already has a known change in the KNL1 gene.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Factors such as lifestyle, environment, age, and medical history also affect how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics focuses on how genetic differences shape responses to medications. It examines relationships between genes and drugs to clarify why the same treatment can work differently from one person to another. With many medicines, genes affect both how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. To read more about this topic, visit the LearnHub.
Drugs influenced by the KNL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, how well a medicine is working, or a family history of unusual drug reactions, talk with your doctor or pharmacist.
History
The KNL1 gene entered the scientific literature under other names, including AF15q14 and later CASC5, reflecting how gene naming often changes as knowledge improves. It first drew attention through chromosome studies and cancer research in the early 2000s, when researchers were mapping genes involved in cell division and inherited conditions. Over time, scientists’ understanding of the gene’s role changed, and the name KNL1 became more widely used as its place in the chromosome separation machinery was clarified. Research interest also grew after harmful variants in this gene were linked to rare inherited conditions affecting growth and brain development. These historical steps shaped today’s understanding and show how a gene can move from a research finding to a recognized part of medical genetics.